Cargando…
Inter- and intraobserver agreement in computed tomography enterography in inflammatory bowel disease
AIM: To evaluate intra- and interobserver agreement in imaging features in inflammatory bowel disease and comparison with fecal calprotectin (FC) levels. METHODS: Our institutional computed tomography enterography (CTE) database was retrospectively queried to identify patients who underwent CTE from...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5143746/ https://www.ncbi.nlm.nih.gov/pubmed/28018107 http://dx.doi.org/10.3748/wjg.v22.i45.10002 |
_version_ | 1782472991327649792 |
---|---|
author | Horvat, Natally Tavares, Camila Carlos Andrade, Adriana Ribas Cabral, Julia Campos Simões Leao-Filho, Hilton Muniz Caiado, Angela Hissae Motoyama Ueda, Serli Kiyomi Nakao Leite, André Zonetti Arruda Sipahi, Aytan Miranda Rocha, Manoel Souza |
author_facet | Horvat, Natally Tavares, Camila Carlos Andrade, Adriana Ribas Cabral, Julia Campos Simões Leao-Filho, Hilton Muniz Caiado, Angela Hissae Motoyama Ueda, Serli Kiyomi Nakao Leite, André Zonetti Arruda Sipahi, Aytan Miranda Rocha, Manoel Souza |
author_sort | Horvat, Natally |
collection | PubMed |
description | AIM: To evaluate intra- and interobserver agreement in imaging features in inflammatory bowel disease and comparison with fecal calprotectin (FC) levels. METHODS: Our institutional computed tomography enterography (CTE) database was retrospectively queried to identify patients who underwent CTE from January 2014 to June 2015. Patient inclusion criteria were confirmed inflammatory bowel disease (IBD) and FC collected < 4 mo after CTE without any change in clinical treatment or surgical treatment during this interval. The exclusion criterion was poor image quality. Two blinded abdominal radiologists, with 12 and 3 years of experience analyzed the CTE regarding localization (small bowel, colonic, both, or no disease detected); type of IBD (inflammatory, stenosing, fistulizing, > 1 pattern, or normal); and signs of active disease (present or absent). In 42 of 44 patients evaluated, routine CTE reports were made by one of the readers who re-evaluated the CTEs ≥ 6 mo later, to determine the intraobserver agreement. FC was considered a sign of disease activity when it was higher than 250 μg/g. RESULTS: Forty-four patients with IBD (38 with Crohn’s disease and 6 with ulcerative colitis) were included. There was a moderate interobserver agreement regarding localization of IBD (κ = 0.540), type of disease (κ = 0.410) and the presence of active signs in CTE (κ = 0.419). There was almost perfect intraobserver agreement regarding localization, type and signs of active disease in IBD. The κ values were 0.902, 0.937 and 0.830, respectively. After a consensus between both radiologists regarding inflammatory activity in CTE, we found that 24 (85.7%) of 28 patients who were classified with active disease had elevated FC, and six (37.5%) of 16 patients without inflammatory activity in CTE had elevated FC (P = 0.003). The correlation between elevated FC and the presence of active disease in CTE was significant (κ = 0.495, P = 0.001). CONCLUSION: We found almost perfect intraobserver and moderate interobserver agreement in the signs of active disease in CTE with concurrence of high FC levels. |
format | Online Article Text |
id | pubmed-5143746 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-51437462016-12-23 Inter- and intraobserver agreement in computed tomography enterography in inflammatory bowel disease Horvat, Natally Tavares, Camila Carlos Andrade, Adriana Ribas Cabral, Julia Campos Simões Leao-Filho, Hilton Muniz Caiado, Angela Hissae Motoyama Ueda, Serli Kiyomi Nakao Leite, André Zonetti Arruda Sipahi, Aytan Miranda Rocha, Manoel Souza World J Gastroenterol Retrospective Study AIM: To evaluate intra- and interobserver agreement in imaging features in inflammatory bowel disease and comparison with fecal calprotectin (FC) levels. METHODS: Our institutional computed tomography enterography (CTE) database was retrospectively queried to identify patients who underwent CTE from January 2014 to June 2015. Patient inclusion criteria were confirmed inflammatory bowel disease (IBD) and FC collected < 4 mo after CTE without any change in clinical treatment or surgical treatment during this interval. The exclusion criterion was poor image quality. Two blinded abdominal radiologists, with 12 and 3 years of experience analyzed the CTE regarding localization (small bowel, colonic, both, or no disease detected); type of IBD (inflammatory, stenosing, fistulizing, > 1 pattern, or normal); and signs of active disease (present or absent). In 42 of 44 patients evaluated, routine CTE reports were made by one of the readers who re-evaluated the CTEs ≥ 6 mo later, to determine the intraobserver agreement. FC was considered a sign of disease activity when it was higher than 250 μg/g. RESULTS: Forty-four patients with IBD (38 with Crohn’s disease and 6 with ulcerative colitis) were included. There was a moderate interobserver agreement regarding localization of IBD (κ = 0.540), type of disease (κ = 0.410) and the presence of active signs in CTE (κ = 0.419). There was almost perfect intraobserver agreement regarding localization, type and signs of active disease in IBD. The κ values were 0.902, 0.937 and 0.830, respectively. After a consensus between both radiologists regarding inflammatory activity in CTE, we found that 24 (85.7%) of 28 patients who were classified with active disease had elevated FC, and six (37.5%) of 16 patients without inflammatory activity in CTE had elevated FC (P = 0.003). The correlation between elevated FC and the presence of active disease in CTE was significant (κ = 0.495, P = 0.001). CONCLUSION: We found almost perfect intraobserver and moderate interobserver agreement in the signs of active disease in CTE with concurrence of high FC levels. Baishideng Publishing Group Inc 2016-12-07 2016-12-07 /pmc/articles/PMC5143746/ /pubmed/28018107 http://dx.doi.org/10.3748/wjg.v22.i45.10002 Text en ©The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. |
spellingShingle | Retrospective Study Horvat, Natally Tavares, Camila Carlos Andrade, Adriana Ribas Cabral, Julia Campos Simões Leao-Filho, Hilton Muniz Caiado, Angela Hissae Motoyama Ueda, Serli Kiyomi Nakao Leite, André Zonetti Arruda Sipahi, Aytan Miranda Rocha, Manoel Souza Inter- and intraobserver agreement in computed tomography enterography in inflammatory bowel disease |
title | Inter- and intraobserver agreement in computed tomography enterography in inflammatory bowel disease |
title_full | Inter- and intraobserver agreement in computed tomography enterography in inflammatory bowel disease |
title_fullStr | Inter- and intraobserver agreement in computed tomography enterography in inflammatory bowel disease |
title_full_unstemmed | Inter- and intraobserver agreement in computed tomography enterography in inflammatory bowel disease |
title_short | Inter- and intraobserver agreement in computed tomography enterography in inflammatory bowel disease |
title_sort | inter- and intraobserver agreement in computed tomography enterography in inflammatory bowel disease |
topic | Retrospective Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5143746/ https://www.ncbi.nlm.nih.gov/pubmed/28018107 http://dx.doi.org/10.3748/wjg.v22.i45.10002 |
work_keys_str_mv | AT horvatnatally interandintraobserveragreementincomputedtomographyenterographyininflammatoryboweldisease AT tavarescamilacarlos interandintraobserveragreementincomputedtomographyenterographyininflammatoryboweldisease AT andradeadrianaribas interandintraobserveragreementincomputedtomographyenterographyininflammatoryboweldisease AT cabraljuliacampossimoes interandintraobserveragreementincomputedtomographyenterographyininflammatoryboweldisease AT leaofilhohiltonmuniz interandintraobserveragreementincomputedtomographyenterographyininflammatoryboweldisease AT caiadoangelahissaemotoyama interandintraobserveragreementincomputedtomographyenterographyininflammatoryboweldisease AT uedaserlikiyominakao interandintraobserveragreementincomputedtomographyenterographyininflammatoryboweldisease AT leiteandrezonettiarruda interandintraobserveragreementincomputedtomographyenterographyininflammatoryboweldisease AT sipahiaytanmiranda interandintraobserveragreementincomputedtomographyenterographyininflammatoryboweldisease AT rochamanoelsouza interandintraobserveragreementincomputedtomographyenterographyininflammatoryboweldisease |